Patent · US Active

Nucleic acid molecule encoding hepatitis B virus core protein and vaccine comprising the same

US9403879B2 · kind B2 · utility

5Cited by
57References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 13, 2012
Grant dateAug 2, 2016
Priority date
Expiry dateFeb 16, 2032

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2730/10171
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are nucleic acid sequences that encode novel consensus amino acid sequence of HBV core protein, as well as genetic constructs/vectors and vaccines that express said protein sequences. Also provided herein are methods for generating an immune response against HBV using the nucleic acid sequences that are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.